Time to result advantage of point-of-care SARS-CoV-2 PCR testing to confirm COVID-19 in emergency department: a retrospective multicenter study

Article Medicine, General & Internal

Rapid Diagnostic Testing for SARS-CoV-2

Paul K. Drain

Summary: This passage discusses the key points of rapid diagnostic testing for SARS-CoV-2, including the authorized testing methods, the target population, and the timing and handling of test results.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Emergency Medicine

Clinical and operational impact of rapid point-of-care SARS-CoV-2 detection in an emergency department

Camille Gerlier et al.

Summary: The study aimed to evaluate the operational impact and potential benefits of implementing Abbott ID NOW (TM) COVID-19 test for rapid point-of-care SARS-CoV-2 detection in an Emergency Department. The results showed that COVID-19 point-of-care testing accelerates clinical decision-making, increases the utilization of recommended treatments like anticoagulants, improves patient flow, and reduces the length of stay in the ED.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2021)

Add to Collection

Article Virology

Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department

Jean-Claude Nguyenvan et al.

Summary: The ID NOW COVID-19 assay showed high sensitivity, specificity, PPV, and NPV when tested directly on nasopharyngeal swabs in an Emergency Department setting. However, when performed in the laboratory using viral transport medium samples, the sensitivity decreased. Three false negative results were reported when using undiluted swabs in the ED from patients with high CT values.

JOURNAL OF CLINICAL VIROLOGY (2021)

Add to Collection

Editorial Material Anesthesiology

Two waves and a high tide: the COVID-19 epidemic in France

Mircea T. Sofonea et al.

ANAESTHESIA CRITICAL CARE & PAIN MEDICINE (2021)

Add to Collection

Article Infectious Diseases

Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel

Samuel Lebourgeois et al.

Summary: The study evaluated the QIAstat-SARS-CoV-2 Panel in detecting SARS-CoV-2 and 21 other respiratory pathogens, showing good agreement with the reference assay. The QIAstat-SARS-CoV-2 provides faster and accurate results for detecting SARS-CoV-2.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Microbiology

Acceptable performance of the Abbott ID NOW among symptomatic individuals with confirmed COVID-19

William Stokes et al.

Summary: This study aimed to evaluate the clinical performance of ID NOW compared to conventional RT-PCR testing. Results showed that ID NOW had a reliable positive percent agreement with RT-PCR when adhering to the manufacturer's recommendations, especially for individuals with symptom onset within 7 days and tested within 1 hour.

JOURNAL OF MEDICAL MICROBIOLOGY (2021)

Add to Collection

Article Infectious Diseases